|
1
|
Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
|
Eur Urol
|
2009
|
2.80
|
|
2
|
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
|
Eur Urol
|
2007
|
2.77
|
|
3
|
A molecular taxonomy for urothelial carcinoma.
|
Clin Cancer Res
|
2012
|
2.37
|
|
4
|
MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
|
Int J Cancer
|
2009
|
2.06
|
|
5
|
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
|
Cancer Res
|
2010
|
1.99
|
|
6
|
Prevention and management of complications following radical cystectomy for bladder cancer.
|
Eur Urol
|
2010
|
1.57
|
|
7
|
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
|
PLoS One
|
2012
|
1.56
|
|
8
|
Treatment delay and prognosis in invasive bladder cancer.
|
J Urol
|
2005
|
1.53
|
|
9
|
Quality of life after cystectomy and urinary diversion: an evidence based analysis.
|
J Urol
|
2005
|
1.53
|
|
10
|
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
|
BMC Med Genomics
|
2008
|
1.24
|
|
11
|
A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1.
|
PLoS One
|
2011
|
1.21
|
|
12
|
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.
|
Epigenetics
|
2012
|
1.07
|
|
13
|
Toward a molecular pathologic classification of urothelial carcinoma.
|
Am J Pathol
|
2013
|
1.03
|
|
14
|
Lymph node metastasis in bladder cancer.
|
Eur Urol
|
2005
|
1.02
|
|
15
|
Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells).
|
Int J Cancer
|
2007
|
1.00
|
|
16
|
Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.
|
Clin Cancer Res
|
2007
|
0.99
|
|
17
|
Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer.
|
J Urol
|
2006
|
0.94
|
|
18
|
Diagnostic delay and prognosis in invasive bladder cancer.
|
Scand J Urol Nephrol
|
2003
|
0.92
|
|
19
|
Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail?
|
Urol Oncol
|
2007
|
0.90
|
|
20
|
Incontinent urinary diversion.
|
BJU Int
|
2008
|
0.90
|
|
21
|
Recurrent and multiple bladder tumors show conserved expression profiles.
|
BMC Cancer
|
2008
|
0.89
|
|
22
|
Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution--a prospective comparative study.
|
Urology
|
2007
|
0.87
|
|
23
|
Pelvic exenteration for advanced and recurrent malignancy.
|
World J Surg
|
2010
|
0.86
|
|
24
|
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
|
Scand J Urol Nephrol
|
2011
|
0.86
|
|
25
|
Microbial flora in ileal and colonic neobladders.
|
Eur Urol
|
2004
|
0.84
|
|
26
|
Quality of life in patients with bladder cancer.
|
Urol Oncol
|
2005
|
0.84
|
|
27
|
Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
|
Scand J Urol Nephrol
|
2007
|
0.83
|
|
28
|
Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey.
|
Scand J Urol Nephrol
|
2011
|
0.83
|
|
29
|
A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden.
|
Scand J Urol Nephrol
|
2009
|
0.82
|
|
30
|
Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol.
|
Scand J Urol
|
2012
|
0.82
|
|
31
|
Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
|
Expert Rev Anticancer Ther
|
2007
|
0.80
|
|
32
|
Mucosal host responses to bacteriuria in colonic and ileal neobladders.
|
Eur Urol
|
2006
|
0.79
|
|
33
|
Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden.
|
Scand J Urol
|
2013
|
0.79
|
|
34
|
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
|
BJU Int
|
2011
|
0.78
|
|
35
|
Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
|
World J Urol
|
2009
|
0.78
|
|
36
|
Urinary diversion after cystectomy for bladder cancer: a population-based study in Sweden.
|
Scand J Urol Nephrol
|
2010
|
0.78
|
|
37
|
The rationale behind recommendations for follow-up after urinary diversion: an evidence-based approach.
|
Scand J Urol Nephrol
|
2007
|
0.77
|
|
38
|
A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies.
|
Eur J Pharm Sci
|
2007
|
0.77
|
|
39
|
Evidence-based urology--a utopia?
|
Eur Urol
|
2004
|
0.75
|
|
40
|
Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5.
|
Eur Urol
|
2009
|
0.75
|
|
41
|
Hematogenous dissemination of transitional cell carcinoma in the bladder to the prostate.
|
Scand J Urol Nephrol
|
2003
|
0.75
|
|
42
|
Working capacity and well-being after radical cystectomy with continent cutaneous diversion.
|
Eur Urol
|
2006
|
0.75
|
|
43
|
The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading.
|
Eur Urol
|
2012
|
0.75
|
|
44
|
Urostomy and health-related quality of life in patients with lower urinary tract dysfunction.
|
Scand J Urol
|
2014
|
0.75
|
|
45
|
Chairmen's summary.
|
Scand J Urol Nephrol Suppl
|
2008
|
0.75
|
|
46
|
Rediversion after urinary diversion: a single-centre experience.
|
Scand J Urol
|
2013
|
0.75
|
|
47
|
Functional results after orthotopic bladder substitution: a prospective multicentre study comparing four types of neobladder.
|
Scand J Urol
|
2013
|
0.75
|